When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 21 Apr 2025
Last updated: 28 Mar 2023

Summary

Your Organizational Guidance

ebpracticenet urges you to prioritize the following organizational guidance:

ScabiësPublished by: Domus MedicaLast published: 2013GalePublished by: Domus MedicaLast published: 2013

Definition

History and exam

Key diagnostic factors

  • infants, children, and older adults
  • history of overcrowding
  • history of itching in family members or close contacts over the same period
  • generalized and intense pruritus, typically worse at night
  • burrows
  • papules, vesicles, excoriations
  • positive ink burrow test

Other diagnostic factors

  • papules on face, neck, palms, and soles in children
  • immunosuppression
  • bullae
  • thick, crusted lesions occurring on elbows, knees, hands, and feet with dystrophic nails
  • nodules

Risk factors

  • overcrowded living conditions/poverty
  • living in close quarters with others who are infected
  • age under 15 or over 65 years
  • sexual contact with new or multiple partners
  • immunosuppression
  • poor hygiene
  • contact with an infected animal
  • contact with contaminated clothing, towels, and bedding
  • winter season

Diagnostic tests

Emerging tests

  • epiluminescence light microscopy

Treatment algorithm

Contributors

Authors

Ryan Harris, MD

Dermatologist

Treasure Valley Dermatology and Skin Cancer Center

Boise

ID

Disclosures

RH declares that he has no competing interests.

Acknowledgements

Dr Ryan Harris would like to gratefully acknowledge Dr Pooja Khera and Dr Laura Korb Ferris, previous contributors to this topic.

Disclosures

PK and LKF declare that they have no competing interests.

Peer reviewers

David Cassarino, MD, PhD

Assistant Professor

Department of Pathology and Laboratory Medicine

University of California

Los Angeles

CA

Disclosures

DC declares that he has no competing interests.

Roderick J. Hay, DM, FRCP, FRCPath, FMedSci

Chairman

International Foundation of Dermatology

London

UK

Disclosures

RJH declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006 Apr 20;354(16):1718-27. Abstract

Heukelbach J, Feldmeier H. Scabies. Lancet. 2006 May 27;367(9524):1767-74. Abstract

Hengge UR, Currie BJ, Jager G, et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006 Dec;6(12):769-79. Abstract

Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000320.Full text  Abstract

Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018 Apr 2;(4):CD012994.Full text  Abstract

Johnstone P, Strong M. Scabies. Clin Evid. 2006 Jun;(15):2284-90. Abstract

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer